-
21
Enfortumab vedotin plus pembrolizumab for previously untreated locally advanced or metastatic urothelial carcinoma: a cost-effectiveness analysis
Published 2025-01-01“…Therapeutic Advances in Medical Oncology…”
Get full text
Article -
22
Navigating the landscape of neoadjuvant immunotherapy for NSCLC: progress and controversies
Published 2025-01-01“…Therapeutic Advances in Medical Oncology…”
Get full text
Article -
23
Treatment-related mortality in head and neck cancer patients receiving chemotherapy and radiation: results of a meta-analysis of published trials
Published 2025-01-01“…Therapeutic Advances in Medical Oncology…”
Get full text
Article